COMPOSITION AND METHOD FOR TREATING COLLAGEN-MEDIATED DISEASE

PROBLEM TO BE SOLVED: To provide a composition and method for treating collagen-mediated disease.SOLUTION: According to the present invention, there is provided a pharmaceutical composition comprising collagenase I purified from histolyticum bacteria has a purity of at least 95% when measured by rev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SABATINO GREGORY L, BASSETT PHILLIP J, DEL TITO BENJAMIN J JR, THARIA HAZEL A, HITCHCOCK ANTONY G
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a composition and method for treating collagen-mediated disease.SOLUTION: According to the present invention, there is provided a pharmaceutical composition comprising collagenase I purified from histolyticum bacteria has a purity of at least 95% when measured by reverse-phase high-performance liquid chromatography.SELECTED DRAWING: None 【課題】コラーゲン媒介疾患を処置するための組成物および方法を提供すること。【解決手段】ヒストリチクス菌から精製されたコラゲナーゼIを含む医薬組成物であって、該コラゲナーゼIは、逆相高性能液体クロマトグラフィーで測定した場合に少なくとも95面積%のタンパク質純度を有する、医薬組成物。【選択図】なし